fashion -WSS

fashion

author：comprehensive 2025-09-27 23:51:52 - browse：2888

WASHINGTON — A White House task force created to work on drug shortage reforms has yet to contact the lawmakers who are writing legislation to stem shortages — and it’s not clear when the task force will recommend policies.

The White House formed a task force at the beginning of 2023 to deal with the issue of persistent drug shortages. Fifty-seven percent of hospital pharmacists said they are facing critical shortages of chemotherapy drugs in a new survey from the American Society of Health-System Pharmacists. Hospital pharmacists also reported significant shortages of steroids, hormonal drugs, and oral liquids such as amoxicillin and lidocaine.

Yet industry and patient representatives who have met with task force members said there has been no indication of when they will make recommendations that could spur federal agencies to act and steer the debate in Congress.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Elizabeth Holmes banned from government health programs

WSS

The surgeon had a dilemma only a Nazi medical text could resolve

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Independent physicians launch a new lobbying group

U.K. researchers warn about biases in medical devices, algorithms

UnitedHealth increases loan offers after Change Healthcare outage

U.K. researchers warn about biases in medical devices, algorithms

Wikipedia

fashion

entertainment

Medical records are filled with copy

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth increases loan offers after Change Healthcare outage

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Eli Lilly, Pfizer, and others want in on the online prescription market

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

State Dept. review finds Biden bears some blame for Afghanistan failures

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Wikipedia

AI generated plenty of interest at JPM but not a lot of trust

Virtual Event: March of the Biosimilars

Test for long Covid? Researchers find new clue in blood samples

Biotech venture capitalists face new demands from investors

Readout Newsletter: Bluebird, CVS, Contineum

Plastic surgeons increase patient psychiatric screenings

explore

hotspot

explore

explore